HBA seeks best leadership initiatives for women

Share this article:
HBA seeks best leadership initiatives for women
HBA seeks best leadership initiatives for women
You have until June 1 to submit your nominations for the 2011 Healthcare Businesswomen's Association ACE Awards program, which honors corporate internal leadership initiatives that support women in the healthcare sector.

Open to companies of all types and sizes, the winner is selected by a panel of leading industry executives, based on five criteria: business performance, stewardship, execution, sustainability and measurable results.

The winning company will be endorsed by the HBA, and recognized by industry experts, peer companies and key stakeholders, as a premier provider of breakthrough programming.

Last year's ACE Award winner was Sanofi-Aventis US for its WISE program (which stands for Women Inspiring Sanofi-Aventis Excellence). With a membership of more than 1,000, this internal women's network fosters the personal and professional leadership development of women working for the company.

For more information on entering the 2011 program, contact Marianne Fray at mfray@hbanet.org or call 973-575-0606. You can download the ACE Awards brochure at hbanet.org.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...